REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2018

Jun 22, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2018-06-20

Reporting Person: VAGELOS P ROY (Director, Chairman of the Board)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-20	Common Stock	M	153274	$16.8	Acquired	553121	Direct
2018-06-20	Common Stock	F	78564	$333.07	Disposed	474557	Direct
2018-06-21	Common Stock	S	400	$323.97	Disposed	474157	Direct
2018-06-21	Common Stock	S	500	$324.18	Disposed	473657	Direct
2018-06-21	Common Stock	S	8047	$325.67	Disposed	465610	Direct
2018-06-21	Common Stock	S	15594	$326.57	Disposed	450016	Direct
2018-06-21	Common Stock	S	19393	$327.48	Disposed	430623	Direct
2018-06-21	Common Stock	S	12426	$328.45	Disposed	418197	Direct
2018-06-21	Common Stock	S	12854	$329.51	Disposed	405343	Direct
2018-06-21	Common Stock	S	3096	$330.32	Disposed	402247	Direct
2018-06-21	Common Stock	S	100	$331.09	Disposed	402147	Direct
2018-06-21	Common Stock	S	1300	$332.8	Disposed	400847	Direct
2018-06-21	Common Stock	S	500	$333.15	Disposed	400347	Direct
2018-06-21	Common Stock	S	300	$335.01	Disposed	400047	Direct
2018-06-21	Common Stock	S	200	$336.87	Disposed	399847	Direct
2018-01-02	Common Stock	G	557	$0.0	Disposed	149160	Indirect
2018-04-02	Common Stock	G	616	$0.0	Disposed	148544	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-20	Non-Qualified Stock Option (right to buy)	$16.8	M	153274	Disposed	2018-12-17	Common Stock (153274)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2310	Indirect
Common Stock	83652	Indirect
Common Stock	1203	Indirect

Footnotes

F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2: Represents volume-weighted average price of sales of 400 shares of Company stock on June 21, 2018 at prices ranging from $323.96 to $323.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.

F3: Represents volume-weighted average price of sales of 500 shares of Company stock on June 21, 2018 at prices ranging from $324.16 to $324.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.

F4: Represents volume-weighted average price of sales of 8,047 shares of Company stock on June 21, 2018 at prices ranging from $325.05 to $325.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.

F5: Represents volume-weighted average price of sales of 15,594 shares of Company stock on June 21, 2018 at prices ranging from $326.00 to $326.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.

F6: Represents volume-weighted average price of sales of 19,393 shares of Company stock on June 21, 2018 at prices ranging from $327.00 to $327.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.

F7: Represents volume-weighted average price of sales of 12,426 shares of Company stock on June 21, 2018 at prices ranging from $328.00 to $328.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.

F8: Represents volume-weighted average price of sales of 12,854 shares of Company stock on June 21, 2018 at prices ranging from $329.00 to $329.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.

F9: Represents volume-weighted average price of sales of 3,096 shares of Company stock on June 21, 2018 at prices ranging from $330.00 to $330.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.

F10: Represents volume-weighted average price of sales of 1,300 shares of Company stock on June 21, 2018 at prices ranging from $332.40 to $332.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.

F11: Represents volume-weighted average price of sales of 500 shares of Company stock on June 21, 2018 at prices ranging from $333.01 to $333.28. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.

F12: Represents volume-weighted average price of sales of 300 shares of Company stock on June 21, 2018 at prices ranging from $335.00 to $335.01. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2018 at each separate price.

F13: By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.

F14: The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.